Khurram Rana
-
- Antibiotic Use and Resistance 4
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 5
- Virology top 10%
- HIV Research and Treatment 3
- Hepatology top 10%
- Hepatitis C virus research 9
-
- HIV/AIDS drug development and treatment 6
- HIV/AIDS Research and Interventions 2
-
- Antibiotics Pharmacokinetics and Efficacy 5
-
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Co-authors
- Michael N. DudleySubasree SrinivasanDavid AltaracAlita A. MillerDrew LewisLan ChenKeith S. KayeBin Du
- Partner nations
- United StatesPolandBrazil
In The Last Decade
Khurram Rana
19 papers receiving 380 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Applied Microbiology and Biotechnology 66
- Molecular Medicine 140
- Virology 62
- Hepatology 75
- Infectious Diseases 107
Countries citing papers authored by Khurram Rana
This map shows the geographic impact of Khurram Rana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khurram Rana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khurram Rana more than expected).
Fields of papers citing papers by Khurram Rana
This network shows the impact of papers produced by Khurram Rana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khurram Rana. The network helps show where Khurram Rana may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Khurram Rana, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)breakdown → | 2023 | 146 |
| 3 | 2022 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 1 | |
| 7 | 2017 | 4 | |
| 8 | 2016 | 9 | |
| 9 | 2016 | 4 | |
| 10 | 2016 | 21 | |
| 11 | 2015 | 2 | |
| 12 | 2015 | 9 | |
| 13 | 2015 | 3 | |
| 14 | 2015 | 1 | |
| 15 | 2011 | 64 | |
| 16 | 2010 | 18 | |
| 17 | 1999 | 32 | |
| 18 | 1999 | 22 | |
| 19 | 1997 | 50 |
About Khurram Rana
Khurram Rana is a scholar working on Applied Microbiology and Biotechnology, Hepatology and Molecular Medicine, having authored 19 papers that have together received 398 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), HIV/AIDS drug development and treatment (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (4 papers), HIV Research and Treatment (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (66 citations), Molecular Medicine (140 citations) and Virology (62 citations). Khurram Rana has collaborated with scholars based in United States, Poland and Brazil. Frequent co-authors include Michael N. Dudley, Subasree Srinivasan, David Altarac, Alita A. Miller, Drew Lewis, Lan Chen, Keith S. Kaye, Bin Du, John P. O’Donnell and Harald H. Reinhart. Their work appears in journals such as Gastroenterology, PLoS ONE and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.